{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:58:52Z","timestamp":1777373932545,"version":"3.51.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PTQ2020-011049"],"award-info":[{"award-number":["PTQ2020-011049"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PID2023-150290OB-I00"],"award-info":[{"award-number":["PID2023-150290OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PID2023-150290OB-I00"],"award-info":[{"award-number":["PID2023-150290OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PID2023-150290OB-I00"],"award-info":[{"award-number":["PID2023-150290OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Catalan AGAUR","award":["2021 SGR00092"],"award-info":[{"award-number":["2021 SGR00092"]}]},{"name":"Catalan AGAUR","award":["2021 SGR00092"],"award-info":[{"award-number":["2021 SGR00092"]}]},{"name":"Catalan AGAUR","award":["2021 SGR00092"],"award-info":[{"award-number":["2021 SGR00092"]}]},{"name":"Spanish Ministry of Science and Innovation and Universities","award":["EUR2023-143461"],"award-info":[{"award-number":["EUR2023-143461"]}]},{"DOI":"10.13039\/501100001872","name":"Centro para el Desarrollo Tecnol\u00f3gico Industrial","doi-asserted-by":"publisher","award":["SNEO 20211019"],"award-info":[{"award-number":["SNEO 20211019"]}],"id":[{"id":"10.13039\/501100001872","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Foundation of the Spanish Association Against Cancer","award":["LAB_LABAE247377LLUC"],"award-info":[{"award-number":["LAB_LABAE247377LLUC"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-025-00835-2","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:52:52Z","timestamp":1763416372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Engineered Mycoplasma pneumoniae targeting dual-species bacterial biofilms: a novel strategy against infections"],"prefix":"10.1038","volume":"11","author":[{"given":"Rocco","family":"Mazzolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andromeda\u2011Celeste","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Collantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jes\u00fas","family":"Grill\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Pi\u00f1ero-Lambea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidre","family":"Gibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Yero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Lluch-Senar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"835_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"835_CR2","unstructured":"WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance. (World Health Organization, Geneva, 2024)."},{"key":"835_CR3","doi-asserted-by":"publisher","first-page":"1137947","DOI":"10.3389\/fcimb.2023.1137947","volume":"13","author":"A Zhao","year":"2023","unstructured":"Zhao, A., Sun, J. & Liu, Y. Understanding bacterial biofilms: From definition to treatment strategies. Front. Cell. Infect. Microbiol. 13, 1137947 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"835_CR4","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/microorganisms11061614","volume":"11","author":"S Sharma","year":"2023","unstructured":"Sharma, S. et al. Microbial biofilm: a review on formation, infection, antibiotic resistance, control measures, and innovative treatment. Microorganisms 11, 1614 (2023).","journal-title":"Microorganisms"},{"key":"835_CR5","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.2147\/IDR.S379502","volume":"15","author":"M Assefa","year":"2022","unstructured":"Assefa, M. & Amare, A. Biofilm-associated multi-drug resistance in hospital-acquired infections: a review. Infect. Drug Resist. 15, 5061\u20135068 (2022).","journal-title":"Infect. Drug Resist."},{"key":"835_CR6","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1007\/s00284-021-02512-x","volume":"78","author":"L Tilouche","year":"2021","unstructured":"Tilouche, L. et al. Staphylococcus aureus ventilator-associated pneumonia: a study of bacterio-epidemiological profile and virulence factors. Curr. Microbiol. 78, 2556\u20132562 (2021).","journal-title":"Curr. Microbiol."},{"key":"835_CR7","doi-asserted-by":"publisher","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres, A. et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT). Eur. Respir. J. 50, 1700582 (2017).","journal-title":"Eur. Respir. J."},{"key":"835_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S2213-2600(14)70171-7","volume":"2","author":"J Rello","year":"2014","unstructured":"Rello, J., Lisboa, T. & Koulenti, D. Respiratory infections in patients undergoing mechanical ventilation. Lancet Respir. Med. 2, 764\u2013774 (2014).","journal-title":"Lancet Respir. Med."},{"key":"835_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jcf.2019.08.006","volume":"19","author":"E Hatziagorou","year":"2020","unstructured":"Hatziagorou, E. et al. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis\u2013data from the European cystic fibrosis society patient registry. J. Cyst. Fibros. 19, 376\u2013383 (2020).","journal-title":"J. Cyst. Fibros."},{"key":"835_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep10241","volume":"5","author":"B Coburn","year":"2015","unstructured":"Coburn, B. et al. Lung microbiota across age and disease stage in cystic fibrosis. Sci. Rep. 5, 10241 (2015).","journal-title":"Sci. Rep."},{"key":"835_CR11","doi-asserted-by":"publisher","unstructured":"Engler, K. et al. Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients. Swiss Med. Wkly. https:\/\/doi.org\/10.4414\/smw.2012.13509 (2012).","DOI":"10.4414\/smw.2012.13509"},{"key":"835_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/ppul.23031","volume":"50","author":"RL Marsh","year":"2015","unstructured":"Marsh, R. L. et al. Detection of biofilm in bronchoalveolar lavage from children with non-cystic fibrosis bronchiectasis. Pediatr. Pulmonol. 50, 284\u2013292 (2015).","journal-title":"Pediatr. Pulmonol."},{"key":"835_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07018-5","volume":"12","author":"M Gomes-Fernandes","year":"2022","unstructured":"Gomes-Fernandes, M. et al. Strain-specific interspecies interactions between co-isolated pairs of Staphylococcus aureus and Pseudomonas aeruginosa from patients with tracheobronchitis or bronchial colonization. Sci. Rep. 12, 3374 (2022).","journal-title":"Sci. Rep."},{"key":"835_CR14","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1128\/AEM.01211-09","volume":"75","author":"L Biswas","year":"2009","unstructured":"Biswas, L., Biswas, R., Schlag, M., Bertram, R. & G\u00f6tz, F. Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl. Environ. Microbiol. 75, 6910\u20136912 (2009).","journal-title":"Appl. Environ. Microbiol."},{"key":"835_CR15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/JB.187.2.554-566.2005","volume":"187","author":"LM Mashburn","year":"2005","unstructured":"Mashburn, L. M., Jett, A. M., Akins, D. R. & Whiteley, M. Staphylococcus aureus Serves as an Iron Source for Pseudomonas aeruginosa during In Vivo Coculture. J. Bacteriol. 187, 554\u2013566 (2005).","journal-title":"J. Bacteriol."},{"key":"835_CR16","first-page":"e02331","volume":"9","author":"RG Abisado","year":"2018","unstructured":"Abisado, R. G., Benomar, S., Klaus, J. R., Dandekar, A. A. & Chandler, J. R. Bacterial Quorum sensing and microbial community interactions. mBio 9, e02331\u201317 (2018).","journal-title":"mBio"},{"key":"835_CR17","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.3389\/fmicb.2019.02880","volume":"10","author":"G Millette","year":"2019","unstructured":"Millette, G. et al. Despite Antagonism in vitro, Pseudomonas aeruginosa Enhances Staphylococcus aureus colonization in a murine lung infection model. Front. Microbiol. 10, 2880 (2019).","journal-title":"Front. Microbiol."},{"key":"835_CR18","doi-asserted-by":"publisher","first-page":"e00873","DOI":"10.1128\/mBio.00873-17","volume":"8","author":"G Orazi","year":"2017","unstructured":"Orazi, G. & O\u2019Toole, G. A. Pseudomonas aeruginosa Alters Staphylococcus aureus sensitivity to Vancomycin in a biofilm model of cystic fibrosis infection. mBio 8, e00873\u201317 (2017).","journal-title":"mBio"},{"key":"835_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/ismej.2015.220","volume":"10","author":"C Frydenlund Michelsen","year":"2016","unstructured":"Frydenlund Michelsen, C. et al. Evolution of metabolic divergence in Pseudomonas aeruginosa during long-term infection facilitates a proto-cooperative interspecies interaction. ISME J. 10, 1323\u20131336 (2016).","journal-title":"ISME J."},{"key":"835_CR20","doi-asserted-by":"publisher","first-page":"19890","DOI":"10.1073\/pnas.0606756104","volume":"103","author":"LR Hoffman","year":"2006","unstructured":"Hoffman, L. R. et al. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. 103, 19890\u201319895 (2006).","journal-title":"Proc. Natl Acad. Sci."},{"key":"835_CR21","doi-asserted-by":"crossref","unstructured":"Hotterbeekx, A., Kumar-Singh, S., Goossens, H. & Malhotra-Kumar, S. In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. Front. Cell. Infect. Microbiol. 7, 1\u201313 (2017).","DOI":"10.3389\/fcimb.2017.00106"},{"key":"835_CR22","doi-asserted-by":"crossref","unstructured":"Alves, P. M. et al. Interaction between Staphylococcus aureus and Pseudomonas aeruginosa is beneficial for colonisation and pathogenicity in a mixed biofilm. Pathog. Dis. 76, 1\u201310 (2018).","DOI":"10.1093\/femspd\/fty003"},{"key":"835_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/thoraxjnl-2018-212616","volume":"74","author":"DH Limoli","year":"2019","unstructured":"Limoli, D. H. & Hoffman, L. R. Help, hinder, hide and harm: what can we learn from the interactions between Pseudomonas aeruginosa and Staphylococcus aureus during respiratory infections?. Thorax 74, 684\u2013692 (2019).","journal-title":"Thorax"},{"key":"835_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jcf.2012.12.003","volume":"12","author":"D Hubert","year":"2013","unstructured":"Hubert, D. et al. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis. J. Cyst. Fibros. 12, 497\u2013503 (2013).","journal-title":"J. Cyst. Fibros."},{"key":"835_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10096-016-2621-0","volume":"35","author":"DH Limoli","year":"2016","unstructured":"Limoli, D. H. et al. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes. Eur. J. Clin. Microbiol. Infect. Dis. 35, 947\u2013953 (2016).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"835_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jcf.2015.10.014","volume":"15","author":"ML Maliniak","year":"2016","unstructured":"Maliniak, M. L., Stecenko, A. A. & McCarty, N. A. A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study. J. Cyst. Fibros. 15, 350\u2013356 (2016).","journal-title":"J. Cyst. Fibros."},{"key":"835_CR27","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.coph.2013.07.004","volume":"13","author":"MS Blackledge","year":"2013","unstructured":"Blackledge, M. S., Worthington, R. J. & Melander, C. Biologically inspired strategies for combating bacterial biofilms. Curr. Opin. Pharmacol. 13, 699\u2013706 (2013).","journal-title":"Curr. Opin. Pharmacol."},{"key":"835_CR28","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1128\/AAC.01249-06","volume":"51","author":"G Donelli","year":"2007","unstructured":"Donelli, G. et al. Synergistic activity of Dispersin B and Cefamandole Nafate in inhibition of Staphylococcal biofilm growth on polyurethanes. Antimicrob. Agents Chemother. 51, 2733\u20132740 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"835_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/antibiotics12010087","volume":"12","author":"FF Tuon","year":"2023","unstructured":"Tuon, F. F. et al. Antimicrobial Treatment of Staphylococcus aureus Biofilms. Antibiotics 12, 87 (2023).","journal-title":"Antibiotics"},{"key":"835_CR30","doi-asserted-by":"publisher","first-page":"1175912","DOI":"10.3389\/fmicb.2023.1175912","volume":"14","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. Antibiofilm effects of punicalagin against Staphylococcus aureus in vitro. Front. Microbiol. 14, 1175912 (2023).","journal-title":"Front. Microbiol."},{"key":"835_CR31","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3389\/fmicb.2020.01744","volume":"11","author":"A Valliammai","year":"2020","unstructured":"Valliammai, A., Selvaraj, A., Yuvashree, U., Aravindraja, C. & Karutha Pandian, S. sarA-dependent antibiofilm activity of thymol enhances the antibacterial efficacy of Rifampicin against Staphylococcus aureus. Front. Microbiol. 11, 1744 (2020).","journal-title":"Front. Microbiol."},{"key":"835_CR32","doi-asserted-by":"publisher","first-page":"e10145","DOI":"10.15252\/msb.202010145","volume":"17","author":"V Garrido","year":"2021","unstructured":"Garrido, V. et al. Engineering a genome-reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo. Mol. Syst. Biol. 17, e10145 (2021).","journal-title":"Mol. Syst. Biol."},{"key":"835_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41587-022-01584-9","volume":"41","author":"R Mazzolini","year":"2023","unstructured":"Mazzolini, R. et al. Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms. Nat. Biotechnol. 41, 1089\u20131098 (2023).","journal-title":"Nat. Biotechnol."},{"key":"835_CR34","doi-asserted-by":"publisher","first-page":"955286","DOI":"10.3389\/fmicb.2022.955286","volume":"13","author":"R Yin","year":"2022","unstructured":"Yin, R., Cheng, J., Wang, J., Li, P. & Lin, J. Treatment of Pseudomonas aeruginosa infectious biofilms: Challenges and strategies. Front. Microbiol. 13, 955286 (2022).","journal-title":"Front. Microbiol."},{"key":"835_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijantimicag.2016.05.008","volume":"48","author":"E Lefebvre","year":"2016","unstructured":"Lefebvre, E., Vighetto, C., Di Martino, P., Larreta Garde, V. & Seyer, D. Synergistic antibiofilm efficacy of various commercial antiseptics, enzymes and EDTA: a study of Pseudomonas aeruginosa and Staphylococcus aureus biofilms. Int. J. Antimicrob. Agents 48, 181\u2013188 (2016).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"835_CR36","doi-asserted-by":"publisher","first-page":"e0258950","DOI":"10.1371\/journal.pone.0258950","volume":"16","author":"SM Daboor","year":"2021","unstructured":"Daboor, S. M., Raudonis, R. & Cheng, Z. Characterizations of the viability and gene expression of dispersal cells from Pseudomonas aeruginosa biofilms released by alginate lyase and tobramycin. PLOS ONE 16, e0258950 (2021).","journal-title":"PLOS ONE"},{"key":"835_CR37","doi-asserted-by":"publisher","first-page":"e0235093","DOI":"10.1371\/journal.pone.0235093","volume":"15","author":"R Fanaei Pirlar","year":"2020","unstructured":"Fanaei Pirlar, R. et al. Combinatorial effects of antibiotics and enzymes against dual-species Staphylococcus aureus and Pseudomonas aeruginosa biofilms in the wound-like medium. PLOS ONE 15, e0235093 (2020).","journal-title":"PLOS ONE"},{"key":"835_CR38","doi-asserted-by":"publisher","unstructured":"Wang, Z. et al. Repurposing DNase I and alginate lyase to degrade the biofilm matrix of dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa grown in artificial sputum medium: In-vitro assessment of their activity in combination with broad-spectrum antibiotics. J. Cyst. Fibros. S1569199324000274, https:\/\/doi.org\/10.1016\/j.jcf.2024.02.012 (2024).","DOI":"10.1016\/j.jcf.2024.02.012"},{"key":"835_CR39","doi-asserted-by":"publisher","first-page":"e70057","DOI":"10.1111\/1751-7915.70057","volume":"17","author":"R Srivastava","year":"2024","unstructured":"Srivastava, R. & Lesser, C. F. Living engineered bacterial therapeutics: emerging affordable precision interventions. Microb. Biotechnol. 17, e70057 (2024).","journal-title":"Microb. Biotechnol."},{"key":"835_CR40","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202211037","volume":"19","author":"A Montero-Blay","year":"2023","unstructured":"Montero-Blay, A. et al. Bacterial expression of a designed single-chain IL-10 prevents severe lung inflammation. Mol. Syst. Biol. 19, e11037 (2023).","journal-title":"Mol. Syst. Biol."},{"key":"835_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66293-2","volume":"10","author":"N Blanco-Cabra","year":"2020","unstructured":"Blanco-Cabra, N. et al. Characterization of different alginate lyases for dissolving Pseudomonas aeruginosa biofilms. Sci. Rep. 10, 9390 (2020).","journal-title":"Sci. Rep."},{"key":"835_CR42","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1128\/AAC.03138-14","volume":"58","author":"V Garrido","year":"2014","unstructured":"Garrido, V. et al. In vivo monitoring of staphylococcus aureus biofilm infections and antimicrobial therapy by [18F] Fluoro-Deoxyglucose-MicroPET in a Mouse Model. Antimicrob. Agents Chemother. 58, 6660\u20136667 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"835_CR43","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1046\/j.1365-2958.2003.03493.x","volume":"48","author":"J Valle","year":"2003","unstructured":"Valle, J. et al. SarA and not \u03c3 B is essential for biofilm development by Staphylococcus aureus. Mol. Microbiol. 48, 1075\u20131087 (2003).","journal-title":"Mol. Microbiol."},{"key":"835_CR44","doi-asserted-by":"publisher","first-page":"782733","DOI":"10.3389\/fcimb.2021.782733","volume":"11","author":"G M\u00e9nard","year":"2021","unstructured":"M\u00e9nard, G., Rouillon, A., Cattoir, V. & Donnio, P.-Y. Galleria mellonella as a suitable model of bacterial infection: past, present and future. Front. Cell. Infect. Microbiol. 11, 782733 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"835_CR45","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1513\/AnnalsATS.201603-194FR","volume":"13","author":"A-A Boisvert","year":"2016","unstructured":"Boisvert, A.-A., Cheng, M. P., Sheppard, D. C. & Nguyen, D. Microbial biofilms in pulmonary and critical care diseases. Ann. Am. Thorac. Soc. 13, 1615\u20131623 (2016).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"835_CR46","doi-asserted-by":"publisher","first-page":"103756","DOI":"10.1016\/j.micpath.2019.103756","volume":"137","author":"R Campos-Silva","year":"2019","unstructured":"Campos-Silva, R., Brust, F. R., Trentin, D. S. & Macedo, A. J. Alternative method in Galleria mellonella larvae to study biofilm infection and treatment. Microb. Pathog. 137, 103756 (2019).","journal-title":"Microb. Pathog."},{"key":"835_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/srep43321","volume":"7","author":"A Crabb\u00e9","year":"2017","unstructured":"Crabb\u00e9, A. et al. Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum. Sci. Rep. 7, 43321 (2017).","journal-title":"Sci. Rep."},{"key":"835_CR48","doi-asserted-by":"crossref","unstructured":"Douglas, S. I., Williams, J. O. & Onyedibia, G. C. Isolation of biofilm producing bacteria from stool samples and their antibiogram. Microbiol. Infect. Dis. 6, 1\u20139 (2022).","DOI":"10.33425\/2639-9458.1146"},{"key":"835_CR49","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/antibiotics11050697","volume":"11","author":"JJ De Waele","year":"2022","unstructured":"De Waele, J. J. et al. The role of abdominal drain cultures in managing abdominal infections. Antibiotics 11, 697 (2022).","journal-title":"Antibiotics"},{"key":"835_CR50","doi-asserted-by":"crossref","unstructured":"Souza, L. C. D. et al. Association between pathogens from tracheal aspirate and oral biofilm of patients on mechanical ventilation. Braz. Oral Res. 31, 1\u20139 (2017).","DOI":"10.1590\/1807-3107bor-2017.vol31.0038"},{"key":"835_CR51","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00405-019-05445-1","volume":"276","author":"R Perez-Tanoira","year":"2019","unstructured":"Perez-Tanoira, R. et al. Bacterial biofilm in salivary stones. Eur. Arch. Otorhinolaryngol. 276, 1815\u20131822 (2019).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"835_CR52","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s00701-016-2977-z","volume":"158","author":"R Mounier","year":"2016","unstructured":"Mounier, R. et al. Biofilm-associated infection: the hidden face of cerebrospinal fluid shunt malfunction. Acta Neurochir, 158, 2321\u20132324 (2016).","journal-title":"Acta Neurochir,"},{"key":"835_CR53","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/antibiotics10070825","volume":"10","author":"H Pinto","year":"2021","unstructured":"Pinto, H., Sim\u00f5es, M. & Borges, A. Prevalence and impact of biofilms on bloodstream and urinary tract infections: a systematic review and meta-analysis. Antibiotics 10, 825 (2021).","journal-title":"Antibiotics"},{"key":"835_CR54","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00264-023-05714-z","volume":"47","author":"L Drago","year":"2023","unstructured":"Drago, L. et al. Dithiotreitol pre-treatment of synovial fluid samples improves microbiological counts in peri-prosthetic joint infection. Int. Orthop. 47, 1147\u20131152 (2023).","journal-title":"Int. Orthop."},{"key":"835_CR55","doi-asserted-by":"publisher","first-page":"100137","DOI":"10.1016\/j.tcsw.2024.100137","volume":"13","author":"A Girma","year":"2025","unstructured":"Girma, A. Staphylococcus aureus: Current perspectives on molecular pathogenesis and virulence. Cell Surf. 13, 100137 (2025).","journal-title":"Cell Surf."},{"key":"835_CR56","doi-asserted-by":"crossref","unstructured":"Qin, S. et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct. Target. Ther. 7, 1\u201327 (2022).","DOI":"10.1038\/s41392-022-01056-1"},{"key":"835_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008281","volume":"16","author":"GB Whitfield","year":"2020","unstructured":"Whitfield, G. B. et al. Discovery and characterization of a Gram-positive Pel polysaccharide biosynthetic gene cluster. PLOS Pathog. 16, e1008281 (2020).","journal-title":"PLOS Pathog."},{"key":"835_CR58","doi-asserted-by":"publisher","first-page":"7528","DOI":"10.1073\/pnas.0700630104","volume":"104","author":"N Cerca","year":"2007","unstructured":"Cerca, N. et al. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly- N -acetylglucosamine surface polysaccharide. Proc. Natl Acad. Sci. 104, 7528\u20137533 (2007).","journal-title":"Proc. Natl Acad. Sci."},{"key":"835_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.micpath.2014.11.005","volume":"77","author":"K-M Chen","year":"2014","unstructured":"Chen, K.-M. et al. The role of pgaC in Klebsiella pneumoniae virulence and biofilm formation. Microb. Pathog. 77, 89\u201399 (2014).","journal-title":"Microb. Pathog."},{"key":"835_CR60","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1128\/IAI.05653-11","volume":"80","author":"LV Bentancor","year":"2012","unstructured":"Bentancor, L. V., O\u2019Malley, J. M., Bozkurt-Guzel, C. & Pier, G. B. Maira-Litr\u00e1n, T. Poly- N -Acetyl-\u03b2-(1-6)-Glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect. Immun. 80, 651\u2013656 (2012).","journal-title":"Infect. Immun."},{"key":"835_CR61","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.1128\/AEM.05814-11","volume":"77","author":"N Yakandawala","year":"2011","unstructured":"Yakandawala, N. et al. Characterization of the Poly-\u03b2-1,6- N -Acetylglucosamine Polysaccharide component of Burkholderia biofilms. Appl. Environ. Microbiol. 77, 8303\u20138309 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"835_CR62","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1128\/JB.186.9.2724-2734.2004","volume":"186","author":"X Wang","year":"2004","unstructured":"Wang, X., Preston, J. F. & Romeo, T. The pgaABCD Locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J. Bacteriol. 186, 2724\u20132734 (2004).","journal-title":"J. Bacteriol."},{"key":"835_CR63","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/JB.187.1.382-387.2005","volume":"187","author":"Y Itoh","year":"2005","unstructured":"Itoh, Y., Wang, X., Hinnebusch, B. J., Preston, J. F. & Romeo, T. Depolymerization of \u03b2-1,6- N -Acetyl- d -Glucosamine disrupts the integrity of diverse bacterial biofilms. J. Bacteriol. 187, 382\u2013387 (2005).","journal-title":"J. Bacteriol."},{"key":"835_CR64","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1128\/JB.00953-06","volume":"189","author":"G Parise","year":"2007","unstructured":"Parise, G., Mishra, M., Itoh, Y., Romeo, T. & Deora, R. Role of a putative polysaccharide Locus in Bordetella biofilm development. J. Bacteriol. 189, 750\u2013760 (2007).","journal-title":"J. Bacteriol."},{"key":"835_CR65","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/AEM.02073-07","volume":"74","author":"EA Izano","year":"2008","unstructured":"Izano, E. A., Amarante, M. A., Kher, W. B. & Kaplan, J. B. Differential Roles of Poly- N -Acetylglucosamine Surface Polysaccharide and Extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis Biofilms. Appl. Environ. Microbiol. 74, 470\u2013476 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"835_CR66","doi-asserted-by":"publisher","first-page":"825856","DOI":"10.3389\/fcimb.2022.825856","volume":"12","author":"IDM Henrique","year":"2022","unstructured":"Henrique, I. D. M. et al. Therapeutic antibodies against shiga toxins: trends and perspectives. Front. Cell. Infect. Microbiol. 12, 825856 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"835_CR67","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/MCG.0000000000001875","volume":"58","author":"MFH Mohamed","year":"2024","unstructured":"Mohamed, M. F. H. et al. Efficacy, safety, and cost-effectiveness of Bezlotoxumab in preventing recurrent clostridioides difficile infection: systematic review and meta-analysis. J. Clin. Gastroenterol. 58, 389\u2013401 (2024).","journal-title":"J. Clin. Gastroenterol."},{"key":"835_CR68","doi-asserted-by":"publisher","first-page":"e00347","DOI":"10.1128\/jcm.00347-22","volume":"60","author":"A Ruzin","year":"2022","unstructured":"Ruzin, A. et al. Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus\/S. aureus skin and soft tissue infection PCR assay on respiratory samples from mechanically ventilated patients for S. aureus screening during the Phase 2 Double-Blind SAATELLITE Study. J. Clin. Microbiol. 60, e00347\u201322 (2022).","journal-title":"J. Clin. Microbiol."},{"key":"835_CR69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcimb.2019.00022","volume":"9","author":"TL Tagliaferri","year":"2019","unstructured":"Tagliaferri, T. L., Jansen, M. & Horz, H.-P. Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy. Front. Cell. Infect. Microbiol. 9, 22 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"835_CR70","doi-asserted-by":"publisher","first-page":"e0182121","DOI":"10.1371\/journal.pone.0182121","volume":"12","author":"M Merabishvili","year":"2017","unstructured":"Merabishvili, M. et al. Stability of bacteriophages in burn wound care products. PLOS ONE 12, e0182121 (2017).","journal-title":"PLOS ONE"},{"key":"835_CR71","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","volume":"8","author":"LL Furfaro","year":"2018","unstructured":"Furfaro, L. L., Payne, M. S. & Chang, B. J. Bacteriophage therapy: clinical trials and regulatory hurdles. Front. Cell. Infect. Microbiol. 8, 376 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"835_CR72","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","volume":"19","author":"P Jault","year":"2019","unstructured":"Jault, P. et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial. Lancet Infect. Dis. 19, 35\u201345 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"835_CR73","doi-asserted-by":"crossref","unstructured":"Palmer, J. D. et al. Engineered probiotic for the inhibition of Salmonella via Tetrathionate-induced production of Microcin H47. ACS Infect. Dis. 4, 39\u201345 (2019).","DOI":"10.1021\/acsinfecdis.7b00114"},{"key":"835_CR74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/btm2.10107","volume":"3","author":"KG Geldart","year":"2018","unstructured":"Geldart, K. G. et al. Engineered E. coli Nissle 1917 for the reduction of vancomycin-resistant Enterococcus in the intestinal tract. Bioeng. Transl. Med. 3, 197\u2013208 (2018).","journal-title":"Bioeng. Transl. Med."},{"key":"835_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15028","volume":"8","author":"IY Hwang","year":"2017","unstructured":"Hwang, I. Y. et al. Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nat. Commun. 8, 15028 (2017).","journal-title":"Nat. Commun."},{"key":"835_CR76","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1021\/sb4000367","volume":"2","author":"K Volzing","year":"2013","unstructured":"Volzing, K., Borrero, J., Sadowsky, M. J. & Kaznessis, Y. N. Antimicrobial peptides targeting gram-negative pathogens, produced and delivered by lactic acid bacteria. ACS Synth. Biol. 2, 643\u2013650 (2013).","journal-title":"ACS Synth. Biol."},{"key":"835_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20200-5","volume":"11","author":"R Drolia","year":"2020","unstructured":"Drolia, R. et al. Receptor-targeted engineered probiotics mitigate lethal Listeria infection. Nat. Commun. 11, 6344 (2020).","journal-title":"Nat. Commun."},{"key":"835_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-020-00153-7","volume":"6","author":"E Gaspari","year":"2020","unstructured":"Gaspari, E. et al. Model-driven design allows growth of Mycoplasma pneumoniae on serum-free media. Npj Syst. Biol. Appl. 6, 33 (2020).","journal-title":"Npj Syst. Biol. Appl."},{"key":"835_CR79","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nmeth.1318","volume":"6","author":"DG Gibson","year":"2009","unstructured":"Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343\u2013345 (2009).","journal-title":"Nat. Methods"},{"key":"835_CR80","doi-asserted-by":"crossref","unstructured":"Kwasny, S. M. & Opperman, T. J. Static biofilm cultures of gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery. Curr. Protoc. Pharmacol. 50, 1\u201326 (2010).","DOI":"10.1002\/0471141755.ph13a08s50"},{"key":"835_CR81","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/21505594.2015.1135289","volume":"7","author":"CJ-Y Tsai","year":"2016","unstructured":"Tsai, C. J.-Y., Loh, J. M. S. & Proft, T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence 7, 214\u2013229 (2016).","journal-title":"Virulence"}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00835-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:07:22Z","timestamp":1763417242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00835-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["835"],"URL":"https:\/\/doi.org\/10.1038\/s41522-025-00835-2","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The results published in this article are covered by patents EP3262061A1\/US10745450B2, EP4121445\/US20230310564\/JP2023518294 and EP4405488\/US20240382537 (licensed to Pulmobiotics S.L). ML-S is one of the shareholders of Pulmobiotics. RM, CP-L and ML-S are employees and have stock options of Pulmobiotics S.L. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}